Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 4:08 pm Purchase | 2024-09-30 | 13G | NURIX THERAPEUTICS INC NRIX | SANDS ARTHUR T | 3,272,832 4.700% | 564,936 (+20.86%) | Filing History |
| 2024-11-14 12:48 pm Sale | 2024-11-14 | 13G | NURIX THERAPEUTICS INC NRIX | Wasatch Advisors LP | 708,377 1.100% | -2,041,368 (-74.24%) | Filing History |
| 2024-11-08 10:52 am Purchase | 2024-09-30 | 13G | NURIX THERAPEUTICS INC NRIX | Wellington Management Group LLP | 3,482,105 5.410% | 2,319,789 (+199.58%) | Filing History |
| 2024-11-07 5:37 pm Sale | 2024-09-30 | 13G | NURIX THERAPEUTICS INC NRIX | Morgan Stanley MS | 1,758,053 2.700% | -1,341,145 (-43.27%) | Filing History |
| 2024-06-07 1:30 pm Purchase | 2024-05-31 | 13G | NURIX THERAPEUTICS INC NRIX | BlackRock, Inc. BLK | 6,042,150 10.200% | 1,398,414 (+30.11%) | Filing History |
| 2024-02-14 4:26 pm Purchase | 2023-12-31 | 13G | NURIX THERAPEUTICS INC NRIX | Redmile Group LLC | 5,021,886 9.900% | 122,114 (+2.49%) | Filing History |
| 2024-02-14 4:21 pm Purchase | 2023-12-31 | 13G | NURIX THERAPEUTICS INC NRIX | BAKER BROS. ADVISORS LP | 4,952,452 9.990% | 150,498 (+3.13%) | Filing History |
| 2024-02-14 10:03 am Sale | 2023-12-31 | 13G | NURIX THERAPEUTICS INC NRIX | T. Rowe Price Associates, Inc. | 2,391,866 4.900% | -861,870 (-26.49%) | Filing History |
| 2024-02-14 08:51 am Purchase | 2023-12-31 | 13G | NURIX THERAPEUTICS INC NRIX | Deep Track Capital, LP | 2,997,830 6.180% | 280,659 (+10.33%) | Filing History |
| 2024-02-14 08:00 am Purchase | 2023-12-31 | 13G | NURIX THERAPEUTICS INC NRIX | SANDS ARTHUR T | 2,707,896 5.400% | 2,707,896 (New Position) | Filing History |
| 2024-02-13 5:09 pm Purchase | 2023-12-29 | 13G | NURIX THERAPEUTICS INC NRIX | VANGUARD GROUP INC | 2,598,097 5.360% | 2,598,097 (New Position) | Filing History |
| 2024-02-09 1:56 pm Purchase | 2024-02-09 | 13G | NURIX THERAPEUTICS INC NRIX | Wasatch Advisors LP | 2,749,745 5.700% | 211,113 (+8.32%) | Filing History |
| 2024-02-09 1:47 pm Purchase | 2023-12-31 | 13G | NURIX THERAPEUTICS INC NRIX | Morgan Stanley MS | 3,099,198 6.400% | 3,099,198 (New Position) | Filing History |
| 2024-01-29 4:00 pm Purchase | 2023-12-31 | 13G | NURIX THERAPEUTICS INC NRIX | ARK Investment Management LLC | 3,194,999 6.590% | 3,194,999 (New Position) | Filing History |
| 2024-01-24 2:27 pm Purchase | 2023-12-31 | 13G | NURIX THERAPEUTICS INC NRIX | BlackRock, Inc. BLK | 4,643,736 9.600% | 501,208 (+12.10%) | Filing History |
| 2024-01-23 10:28 am Sale | 2023-12-31 | 13G | NURIX THERAPEUTICS INC NRIX | STATE STREET CORP STT | 921,322 1.900% | -1,586,665 (-63.26%) | Filing History |
| 2023-02-24 4:13 pm Purchase | 2023-02-16 | 13G | NURIX THERAPEUTICS INC NRIX | Deep Track Capital, LP | 2,717,171 5.750% | 450,602 (+19.88%) | Filing History |
| 2023-02-14 4:21 pm Purchase | 2022-12-31 | 13G | NURIX THERAPEUTICS INC NRIX | Redmile Group LLC | 4,899,772 9.900% | 1,941,488 (+65.63%) | Filing History |
| 2023-02-14 4:04 pm Sale | 2022-12-31 | 13G | NURIX THERAPEUTICS INC NRIX | Third Rock Ventures III L.P. | 184,544 0.400% | -2,366,213 (-92.77%) | Filing History |
| 2023-02-14 4:00 pm Purchase | 2022-12-31 | 13G | NURIX THERAPEUTICS INC NRIX | BAKER BROS. ADVISORS LP | 4,801,954 9.990% | 2,347,872 (+95.67%) | Filing History |